Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO)

Historical Holders from Q4 2023 to Q1 2025

Symbol
LXEO on Nasdaq
CUSIP
52886X107
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
33.1M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
29.5M
Holdings value
$194M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
89
Number of buys
54
Number of sells
-19
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 13.1% $14.9M 4.34M JANUS HENDERSON GROUP PLC Dec 31, 2024
Adage Capital Management, L.P. 6.68% $7.59M 2.21M Adage Capital Management, L.P. Dec 31, 2024
MIZUHO FINANCIAL GROUP INC 5.8% $6.62M 1.93M Mizuho Financial Group, Inc. Dec 31, 2024
BlackRock, Inc. 5.5% $6.26M 1.82M BlackRock, Inc. Dec 31, 2024
EVENTIDE ASSET MANAGEMENT, LLC 3.73% $4.24M 1.23M Eventide Asset Management, LLC Dec 31, 2024
Omega Fund VI, L.P. 3.6% $4.07M 1.18M Omega Fund VI, L.P. Dec 31, 2024

Institutional Holders of Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 35.2K $122K -$40.6K $3.43 2
2024 Q4 29.5M $194M -$4.09M $6.58 89
2024 Q3 29.7M $269M +$10.3M $9.04 67
2024 Q2 26.6M $426M +$55.3M $16.04 57
2024 Q1 23.1M $362M +$108M $15.68 54
2023 Q4 16.2M $217M +$217M $13.42 31